Trial testing safety of Parkinson’s vaccine gets $4M for 2 more years
AC Immune has been awarded $4 million to extend the first part of an ongoing clinical trial that’s testing ACI-7104, its experimental vaccine targeting alpha-synuclein protein clumping, which is a…